HH 102007 analogue - Haihe Biopharma
Alternative Names: HH-102007 analogue - Haihe BiopharmaLatest Information Update: 03 Jul 2024
At a glance
- Originator HaiHe Biopharma
- Class Antineoplastics; Small molecules
- Mechanism of Action Poly(ADP-ribose) polymerase-1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Cancer